These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 1916446)
1. [Effect of ranitidine on the pharmacokinetics of theophylline in patients with obstructive pulmonary disease]. Paranos S; Despotović N; Vidanović M; Bojović I; Milovanović M; Dmitrović V; Bozović M Glas Srp Akad Nauka Med; 1991; (41):45-52. PubMed ID: 1916446 [TBL] [Abstract][Full Text] [Related]
2. [The effect of ranitidine on theophylline pharmacokinetics in patients with obstructive lung disease]. Paranos S; Despotović N; Vidanović M; Bojović I; Milovanović M; Dmitrović V Plucne Bolesti; 1991; 43(1-2):89-93. PubMed ID: 1766997 [TBL] [Abstract][Full Text] [Related]
3. Combined administration of controlled release theophylline and ranitidine: a 53-day controlled survey in patients with chronic obstructive lung disease (COLD) and peptic disease. Dal Negro R; Turco P; Pomari C; Trevisan F; De Conti F; Cordaro CI Br J Clin Pract; 1987 Nov; 41(11):1004-8. PubMed ID: 3504314 [No Abstract] [Full Text] [Related]
4. Pharmacokinetics of theophylline and the H2-antagonist drugs cimetidine and ranitidine. Dal Negro R; Pomari C; Zoccatelli O; Trevisan F; Carloni C; Turco P Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):221-6. PubMed ID: 6325354 [TBL] [Abstract][Full Text] [Related]
5. Effects of cimetidine and ranitidine on the pharmacokinetics of a chronotherapeutically formulated once-daily theophylline preparation (Uniphyl). Fraser IM; Buttoo KM; Walker SE; Stewart JH; Babul N Clin Ther; 1993; 15(2):383-93. PubMed ID: 8519046 [TBL] [Abstract][Full Text] [Related]
6. Comparative dose study of a theophylline sustained-release tablet formulation after repeated administrations. Cova D; Cuglituri G; Rossini L; Bonfardeci G Int J Clin Pharmacol Ther Toxicol; 1989 Jun; 27(6):273-5. PubMed ID: 2737795 [TBL] [Abstract][Full Text] [Related]
7. Comparative investigation of the influence of nizatidine, ranitidine, and cimetidine on the steady-state pharmacokinetics of theophylline in COPD patients. Bachmann K; Sullivan TJ; Mauro LS; Martin M; Jauregui L; Levine L J Clin Pharmacol; 1992 May; 32(5):476-82. PubMed ID: 1587967 [TBL] [Abstract][Full Text] [Related]
8. [Evaluation of theophylline population pharmacokinetics in adult hospitalized patients using NONMEM analysis]. Li Z; Chen G Zhongguo Yao Li Xue Bao; 1994 May; 15(3):267-70. PubMed ID: 7976385 [TBL] [Abstract][Full Text] [Related]
9. [The effect of pretreatment with ranitidine on the pharmacokinetics and gastrointestinal transit of a sustained-release theophylline preparation]. Wilson CG; Washington N; Greaves JL; Blackshaw PE; Perkins AC; Barkworth MF; Rehm KD Arzneimittelforschung; 1998 May; 48(5A):561-8. PubMed ID: 9676345 [TBL] [Abstract][Full Text] [Related]
10. Bronchodilator effects of terbutaline and theophylline alone and in combination in patients with chronic obstructive lung disease. Baadsgaard O; Oberg B; Thomsen L; Klitgaard N; Simonsen E Allergol Immunopathol (Madr); 1985; 13(6):471-4. PubMed ID: 2870630 [TBL] [Abstract][Full Text] [Related]
11. [Influence of the combination of theophylline and beta 2 agonists by oral route on pulmonary function of patients with chronic obstructive lung disease]. Carvalho-Pinto RM; Terra Filho M; Cukier A; Santos SR; Verrastro C; Teixeira LR; Vargas FS Rev Hosp Clin Fac Med Sao Paulo; 1991; 46(4):166-9. PubMed ID: 1843713 [TBL] [Abstract][Full Text] [Related]
13. Chronopharmacodynamics and kinetics after symmetric and asymmetric multiple theophylline doses in patients with chronic obstructive pulmonary disease. Gimeno F; van Veenen R; Berg WC; Steenhuis EJ; Jonkman JH; Weibel MA Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):7-12. PubMed ID: 2744908 [TBL] [Abstract][Full Text] [Related]
14. Effect of pretreatment with ranitidine on the pharmacokinetics and gastrointestinal transit of a sustained release theophylline preparation. Wilson CG; Washington N; Greaves JL; Blackshaw PE; Perkins AC; Barkworth MF; Rehm KD Arzneimittelforschung; 1991 Nov; 41(11):1154-9. PubMed ID: 1810260 [TBL] [Abstract][Full Text] [Related]
15. Effect of theophylline in chronic obstructive lung disease. Umut S; Gemicioğlu B; Yildirim N; Barlas A; Ozüner Z Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):149-52. PubMed ID: 1592541 [TBL] [Abstract][Full Text] [Related]
16. [Euphylong in patients with chronic obstructive airway diseases]. Kublik A; von Wichert P Pneumologie; 1991 Nov; 45 Suppl 4():858-62. PubMed ID: 1812480 [TBL] [Abstract][Full Text] [Related]
17. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease. Fontana G; Cresci F; Lo Sapio P; Panuccio P Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008 [TBL] [Abstract][Full Text] [Related]
18. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases]. Salikova VV; Nonikov VE; Belousov IuB Ter Arkh; 1993; 65(8):41-4. PubMed ID: 8211801 [TBL] [Abstract][Full Text] [Related]
19. [Prescription of Theostat 300 as a single evening dose]. Germouty J; Bida C; Moreau L Rev Pneumol Clin; 1987; 43(5):262-5. PubMed ID: 3324266 [TBL] [Abstract][Full Text] [Related]
20. Theophylline pharmacokinetics in patients with mild or severe airway obstruction. Rizzo A; Mirabella A; Ferrara G; Pipitone P; Bellia V; Bonsignore G Bull Eur Physiopathol Respir; 1982; 18(6):811-8. PubMed ID: 6927536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]